Ciencias de la vida
Soybean variety 5PDBT29
22/09/2026 -
A novel soybean variety, designated 5PDBT29 is provided. Also provided are the seeds of soybean variety 5PDBT29, cells from soybean variety 5PDBT29, plants of soybean 5PDBT29, and plant parts of...
KEY TARGETS FOR TRANSGENE-FREE GENOME EDITING TO GENERATE HLB RESISTANT/TOLERANT CITRUS VARIETIES
24/09/2026 -
Citrus huanglongbing (HLB) caused by 'Candidatus Liberibacter asiaticus' (CLas) is the most devastating citrus disease worldwide. With CLas infection, RNA-seq analyses were performed on...
COMPOSITE MUTAGENESIS BREEDING METHOD AND SYSTEM FOR CREATING NEW GERMPLASM OF HIGH SEED-SETTING LEYMUS CHINENSIS
28/09/2026 -
The present invention discloses a composite mutagenesis breeding method and system for creating new germplasm of Leymus chinensis with high seed-setting rate, belonging to the technical field of...
METHODS AND SYSTEMS FOR ESTIMATING PORE THROAT DISTRIBUTION IN POROUS MEDIA
22/10/2026 -
[0000] A computer-implemented method for estimating pore throat distribution within a subterranean formation includes receiving a digital image of a rock from the subterranean formation,...
SYSTEM AND METHOD FOR DETECTING FAULTS BETWEEN TURNS IN WINDINGS OF ALTERNATING CURRENT ELECTRICAL MACHINES (Machine-translation by Google Translate, not legally binding)
15/09/2026 -
A system and method for detecting turns in the windings of AC electrical machines utilizes at least the current measurements of the machine being diagnosed and uses them to obtain instantaneous...
EXTRACT OF HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS AND APPLICATION IN SKINCARE PRODUCTS THEREOF
17/09/2026 -
The invention provides a extract of human umbilical cord mesenchymal stem cells and an application in skincare products thereof, belonging to the fields of biotechnology and cosmetics. The extract...
NOVEL SOURCE OF HYALURONIC ACID FROM CAMEL'S LIMBS
24/09/2026 -
This invention relates to a novel method for extracting hyaluronic acid (HA) from a newly identified animal-derived source. The method preserves HA's bioactivity while increasing productivity and...
METHOD FOR TREATING MELASMA USING LONG-ACTING WHITENING INJECTION COMBINED WITH IPL AND 1064 NM LASER
02/10/2026 -
The invention provides a method for treating melasma using a long-acting whitening injection combined with IPL and 1064 nm laser, belonging to the technical field of medical aesthetics. A...
METHODS OF USING A COMBINATION OF ALTERNATING ELECTRIC FIELDS, RADIATION THERAPY, TEMOZOLOMIDE AND CHECKPOINT INHIBITORS
01/10/2026 -
[0000] Disclosed are methods of treating a subject having glioblastoma comprising a treatment phase and a maintenance phase, wherein the treatment phase comprises applying an alternating...
Lure hard bait lacquer coating process
07/08/2026 -
The invention discloses a Leya hard bait lacquer coating process, which relates to the technical field of fishing gear, and comprises the following steps: carrying out surface pretreatment on a...
PORTABLE PUBLIC SAFETY ANSWERING POINT (PSAP)
01/10/2026 -
[0000] Particular example embodiments described herein can provide for a system, an apparatus, and a method for helping to enable a portable PSAP. The portable PSAP can include a protective...
MODIFIER FOR ANIMAL PROTEIN
01/10/2026 -
The purpose of the present invention is to provide a technology for modifying animal protein. A modified animal protein-containing dry composition obtained by a method including an enzyme...
COMBINATION THERAPY COMPRISING A MULTI-SPECIFIC BINDING AGENT TARGETING PD-1/PD-L1 AND VEGF/VEGFR AND A MULTI-SPECIFIC BINDING AGENT TARGETING EPCAM AND 4-1BB FOR CANCER TREATMENT
17/09/2026 -
The present disclosure relates to combination therapy using a binding agent that binds to (i) PD-1, PD-L1, or both, and (ii) VEGF, VEGF receptor (VEGFR), or both in combination with a binding...
SOLID DISPERSIONS OF ELACRIDAR
17/09/2026 -
The present invention relates to a solid dispersion comprising: elacridar or a pharmaceutically acceptable salt thereof, and one or more carrier materials; wherein the one or more carrier...
CRYSTAL FORM OF A PARP1 INHIBITOR SALT AND PREPARATION THEREOF
17/09/2026 -
A crystal form (Type A) of the bis-tartrate ((2R,3R)) salt of 7-((4-(2-fluoro-6- (methylcarbamoyl)pyridin-3-yl)piperazin-1-yl)methyl)-3,6-difluoropyrazolo[1,5- a]quinoxalin-4(5H)-one (Formula...
ALGINATE-BASED HYDROGEL COMPOSITIONS AND USES THEREOF
17/09/2026 -
The present invention relates to hydrogel compositions comprising oxidized and chemically modified alginate. Such hydrogel is suitable for encapsulating active ingredients, such as T cells, with...
VISMODEGIB FORMULATION
17/09/2026 -
Presented invention relates to a pharmaceutical composition comprising polymorphic Form B of Vismodegib having particle size distribution D(90) between 150 µm and 190 µm, preferably between 160...
PDL1-TARGETED IL-12 FUSION PROTEINS
17/09/2026 -
This disclosure relates, inter alia, to compositions comprising and methods making and using fusion proteins comprising a PDL1 binding domain and a human IL-12 domain, including immune cells...
SUBSTITUTED 1 H,4H,5H-PYRROLO[3,2-B]PYRIDIN-5-ONE COMPOUNDS AS TEAD BINDERS AND/OR INHIBITORS OF YAP-TEAD AND TAZ-TEAD PROTEIN-PROTEIN INTERACTION
17/09/2026 -
The present invention relates to bicyclic compounds. These bicyclic compounds are useful as TEAD binders and/or inhibitors of YAP-TEAD and TAZ-TEAD protein-protein interaction or binding and for...
T CELL RECEPTORS (TCRS) TARGETING ACTIN-LIKE PROTEIN 8 (ACTL8) FOR USE IN THERAPY
17/09/2026 -
The present invention provides, amongst others, a T cell receptor (TCR) that binds to an epitope of human Actin-like protein 8 (ACTL8), wherein said epitope consists of the amino acid sequence of...
DHX8/16 INHIBITORS
17/09/2026 -
The invention relates to compounds of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of diseases and disorders in mammals,...
Actividades asistenciales
Agroalimentación
Automoción y nueva movilidad
Energía sostenible y eficiente
Materiales avanzados
Medio ambiente y sostenibilidad
Patrimonio natural y cultural
Procesos productivos e industria 4.0
Química y biotecnología
Salud y calidad de vida
Transformación digital



